IV therapy delivers superior results with 90-100% bioavailability compared to 10-50% for oral supplements, making NAD IV with glutathione the most effective delivery method
With a concentration of 600ppm Glutathione along with Niacinamide, Vitamin C, Ceramides, and Peptides, the cream helps reduce the appearance of hyperpigmentation, improve skin elasticity, and impart a healthy, even radiance
In patients with cirrhosis, glutamine has been shown to be the alternate route of greater action for detoxifying ammonia, and under conditions of stress, can remove up to 80% of NH3.48 Finally, as mentioned above, diet and exercise play an essential role in those patients
Improved glycaemic control and cardiometabolic markers (e.g., inflammatory lipids and blood pressure reported in readouts)
Ivacaftor (Trikafta) (CP.PHAR.440) (PDF) Eliglustat (Cerdelga) (CP.PHAR.153) (PDF) Elinzanetant (Lynkuet) (CP.PMN.304) (PDF) Elivaldogene Autotemcel (Skysona) (CP.PHAR.556) (PDF) Elosulfase Alfa (Vimizim) (CP.PHAR.162) (PDF) Elotuzumab (Empliciti) (CP.PHAR.308) (PDF) Elranatamab-bcmm (Elrexfio) (CP.PHAR.652) (PDF) Eltrombopag (Alvaiz, Promacta) (CP.PHAR.180) (PDF) Eluxadoline (Viberzi) (CP.PMN.170) (PDF) Emapalumab-lzsg (Gamifant) (CP.PHAR.402) (PDF) Emicizumab-kxwh (Hemlibra) (CP.PHAR.370) (PDF) Emtricitabine/Tenofovir Alafenamide (Descovy) (CP.PMN.235) (PDF) Enasidenib (Idhifa) (CP.PHAR.363) (PDF) Encorafenib (Braftovi) (CP.PHAR.127) (PDF) Enfortumab Vedotin-ejfv (Padcev) (CP.PHAR.455) (PDF) Enfuvirtide (Fuzeon) (CP.PHAR.41) (PDF) Enoxaparin (Lovenox) (CP.PHAR.224) (PDF) Ensartinib (Ensacove) (CP.PHAR.712) (PDF) Entecavir (Baraclude) (HIM.PA.08) (PDF) Entrectinib (Rozlytrek) (CP.PHAR.441) (PDF) Enzalutamide (Xtandi) (CP.PHAR.106) (PDF) Epcoritamab-bysp (Epkinly) (CP.PHAR.634) (PDF) Epinephrine (Epipen, Epipen Jr, Neffy, Auvi-Q) (CP.PCH.55) (PDF) Eplontersen (Wainua) (CP.PHAR.633) (PDF) Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (CP.PHAR.237) (PDF) Epoprostenol (Flolan, Veletri) (CP.PHAR.192) (PDF) Eptinezumab-jjmr (Vyepti) (HIM.PA.SP64) (PDF) Erdafitinib (Balversa) (CP.PHAR.423) (PDF) Erenumab-aooe (Aimovig) (HIM.PA.SP65) (PDF) Eribulin Mesylate (Halaven) (CP.PHAR.318) (PDF) Erlotinib (Tarceva) (CP.PHAR.74) (PDF) Erwinia Asparaginase (Rylaze) (CP.PHAR.301) (PDF) Esketamine (Spravato) (CP.PMN.199) (PDF) Estradiol Vaginal Ring (Femring) (CP.PMN.263) (PDF) Etelcalcetide (Parsabiv) (CP.PHAR.379) (PDF) Eteplirsen (Exondys 51) (CP.PHAR.288) (PDF) Etranacogene Dezaparvovec-drlb (Hemgenix) (CP.PHAR.580) (PDF) Etripamil (Cardamyst) (CP.PMN.306) (PDF) Etuvetidigene Autotemcel (Waskyra) (CP.PHAR.735) (PDF) Everolimus (Afinitor, Afinitor Disperz, Zortress) (CP.PHAR.63) (PDF) Evinacumab-dgnb (Evkeeza) (HIM.PA.166) (PDF) Evolocumab (Repatha) (HIM.PA.156) (PDF) Exagamglogene autotemcel (Casgevy) (CP.PHAR.603) (PDF) Factor IX (Human, Recombinant) (CP.PHAR.218) (PDF) Factor IX Complex, Human (Profilnine) (CP.PHAR.219) (PDF) Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (CP.PHAR.220) (PDF) Factor VIII (Human, Recombinant) (CP.PHAR.215) (PDF) Factor VIII/von Willebrand Factor Complex (Human Alphanate, Humate-P, Wilate)
